Compile Data Set for Download or QSAR
Report error Found 377 Enz. Inhib. hit(s) with all data for entry = 8416
LigandPNGBDBM247994(US9434724, 65)
Affinity DataIC50: 2.43E+3nMpH: 7.4Assay Description:hERG study was conducted with an automated patch clamp machine, Qpatch-48HT (Sophion Biosciences, Denmark). Cultured CHO cells stably expressing hERG...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247999(US9434724, 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248000(US9434724, 27 | US9434724, 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248001(US9434724, 17 | US9434724, 10)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248002(US9434724, 11)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248003(US9434724, 12)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248004(US9434724, 13)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248005(US9434724, 14)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248006(US9434724, 15)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248007(US9434724, 16)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248001(US9434724, 17 | US9434724, 10)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248009(US9434724, 18)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248010(US9434724, 19)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248011(US9434724, 20)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247958(US9434724, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248012(US9434724, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248013(US9434724, 23)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247959(US9434724, 24)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248014(US9434724, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248015(US9434724, 26)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248000(US9434724, 27 | US9434724, 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248017(US9434724, 28)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248018(US9434724, 29)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248019(US9434724, 30)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248021(US9434724, 32)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248022(US9434724, 33)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247960(US9434724, 34)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247988(US9434724, 35)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248023(US9434724, 36)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247961(US9434724, 37)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247989(US9434724, 38)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248024(US9434724, 39)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247962(US9434724, 40)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247963(US9434724, 41)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247964(US9434724, 42)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247965(US9434724, 43)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248025(US9434724, 45)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247990(US9434724, 46)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247967(US9434724, 47)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247968(US9434724, 48)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247969(US9434724, 49)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247970(US9434724, 50)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248026(US9434724, 51)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248027(US9434724, 52)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247971(US9434724, 53)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247972(US9434724, 54)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248028(US9434724, 55)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248029(US9434724, 56)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 377 total ) | Next | Last >>
Jump to: